XML 46 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Renasant Corporation (Parent Company Only) Condensed Financial Information
12 Months Ended
Dec. 31, 2022
Condensed Financial Information Disclosure [Abstract]  
Renasant Corporation (Parent Company Only) Condensed Financial Information Renasant Corporation (Parent Company Only) Condensed Financial Information
(In Thousands)
Balance Sheets
  
December 31,
 20222021
Assets
Cash and cash equivalents(1)
$167,727 $184,426 
Investments— 2,009 
Investment in bank subsidiary(2)
2,391,721 2,477,917 
Accrued interest receivable on bank balances(2)
Other assets28,468 28,751 
Total assets$2,587,919 $2,693,107 
Liabilities and shareholders’ equity
Junior subordinated debentures$112,042 $111,373 
Subordinated notes316,091 359,419 
Other liabilities23,770 12,462 
Shareholders’ equity2,136,016 2,209,853 
Total liabilities and shareholders’ equity$2,587,919 $2,693,107 
(1)Eliminates in consolidation, with the exception of $1,889 and $1,857, in 2022 and 2021, respectively, pledged for collateral and held at non-subsidiary bank
(2)Eliminates in consolidation
Statements of Income
  
Year Ended December 31,
 202220212020
Income
Dividends from bank subsidiary(1)
$68,114 $80,965 $81,443 
Interest income from bank subsidiary(1)
Other dividends134 80 93 
Other income85 32 74 
Total income68,338 81,084 81,619 
Expenses24,264 18,661 15,179 
Income before income tax benefit and equity in undistributed net income of bank subsidiary44,074 62,423 66,440 
Income tax benefit(6,231)(4,795)(3,889)
Equity in undistributed net income of bank subsidiary(1)
115,763 108,674 13,322 
Net income$166,068 $175,892 $83,651 
(1)Eliminates in consolidation
 
Statements of Cash Flows
  
Year Ended December 31,
 202220212020
Operating activities
Net income$166,068 $175,892 $83,651 
Adjustments to reconcile net income to net cash provided by operating activities:
Equity in undistributed net income of bank subsidiary(115,763)(108,674)(13,322)
Amortization/depreciation1,478 891 692 
Increase (decrease) in other assets284 (5,628)(256)
Increase in other liabilities9,225 6,952 10,932 
Net cash provided by operating activities61,292 69,433 81,697 
Investing activities
Purchases of securities available for sale— — (6,104)
Sales and maturities of securities and available for sale2,000 5,100 541 
Other investing activities— (100,000)— 
Net cash (used in) provided by investing activities2,000 (94,900)(5,563)
Financing activities
Cash paid for dividends(49,991)(50,017)(50,134)
Repurchase of shares in connection with stock repurchase program— (21,315)(24,569)
Repayment of long-term debt(30,000)(45,000)— 
Proceeds from issuance of long-term debt— 197,061 98,266 
Net cash (used in) provided by financing activities(79,991)80,729 23,563 
(Decrease) increase in cash and cash equivalents(16,699)55,262 99,697 
Cash and cash equivalents at beginning of year184,426 129,164 29,467 
Cash and cash equivalents at end of year$167,727 $184,426 $129,164